Tumor-infiltrating HLA-matched CD4⁺ T cells retargeted against Hodgkin and Reed–Sternberg cells

References

• Hodgkin T. On some Morbid Appearances of the Absorbent Glands and Spleen. Med Chir Trans 1832; 17:68-114; PMID:20895597; http://dx.doi.org/10.1177/095952873201700106
   PubMedGoogle Scholar
• Drexler HG. Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. Leuk Lymphoma 1992; 8:283-313; PMID:1337848; http://dx.doi.org/10.3109/10428199209051008
   PubMed Web of Science ®Google Scholar
• Küppers R, Schwering I, Bräuninger A, Rajewsky K, Hansmann ML. Biology of Hodgkin's lymphoma. Ann Oncol 2002; 13(Suppl 1):11-8; PMID:12078890; http://dx.doi.org/10.1093/annonc/13.S1.11
   PubMed Web of Science ®Google Scholar
• Rengstl B, Newrzela S, Heinrich T, Weiser C, Thalheimer FB, Schmid F, Warner K, Hartmann S, Schroeder T, Kuppers R et al. Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed-Sternberg cells. Proc Natl Acad Sci U S A 2013; 110:20729-34; PMID:24302766; http://dx.doi.org/10.1073/pnas.1312509110
   PubMed Web of Science ®Google Scholar
• Rengstl B, Rieger MA, Newrzela S. On the origin of giant cells in Hodgkin lymphoma. Commun Integr Biol 2014; 7:e28602; PMID:25346790; http://dx.doi.org/10.4161/cib.28602
   PubMedGoogle Scholar
• Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood 2002; 99:4283-97; PMID:12036854; http://dx.doi.org/10.1182/blood-2002-01-0099
   PubMed Web of Science ®Google Scholar
• Teruya-Feldstein J, Tosato G, Jaffe ES. The role of chemokines in Hodgkin's disease. Leuk Lymphoma 2000; 38:363-71; PMID:10830743; http://dx.doi.org/10.3109/10428190009087027
   PubMed Web of Science ®Google Scholar
• Poppema S, Bhan AK, Reinherz EL, Posner MR, Schlossman SF. In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease. Blood 1982; 59:226-32; PMID:7034810
   PubMed Web of Science ®Google Scholar
• Ishida T, Ishii T, Inagaki A, Yano H, Komatsu H, Iida S, Inagaki H, Ueda R. Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege. Cancer Res 2006; 66:5716-22; PMID:16740709; http://dx.doi.org/10.1158/0008-5472.CAN-06-0261
   PubMed Web of Science ®Google Scholar
• Marshall NA, Christie LE, Munro LR, Culligan DJ, Johnston PW, Barker RN, Vickers MA. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 2004; 103:1755-62; PMID:14604957; http://dx.doi.org/10.1182/blood-2003-07-2594
   PubMed Web of Science ®Google Scholar
• Fischer M, Juremalm M, Olsson N, Backlin C, Sundstrom C, Nilsson K, Enblad G, Nilsson G. Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue. Int J Cancer 2003; 107:197-201; PMID:12949794; http://dx.doi.org/10.1002/ijc.11370
   PubMed Web of Science ®Google Scholar
• van den Berg A, Visser L, Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. Am J Pathol 1999; 154:1685-91; PMID:10362793; http://dx.doi.org/10.1016/S0002-9440(10)65424-7
   PubMed Web of Science ®Google Scholar
• Ohshima K, Tutiya T, Yamaguchi T, Suzuki K, Suzumiya J, Kawasaki C, Haraoka S, Kikuchi M. Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (H&RS) cells in Hodgkin disease: Relation with expression of CXC and CC chemokines on H&RS cells. Int J Cancer 2002; 98:567-72; PMID:11920617; http://dx.doi.org/10.1002/ijc.10218
   PubMed Web of Science ®Google Scholar
• Hartmann S, Jakobus C, Rengstl B, Doring C, Newrzela S, Brodt HR, Wolf T, Hansmann ML. Spindle-shaped CD163+ rosetting macrophages replace CD4+ T-cells in HIV-related classical Hodgkin lymphoma. Mod Pathol 2013; 26:648-57; PMID:23307058; http://dx.doi.org/10.1038/modpathol.2012.217
   PubMed Web of Science ®Google Scholar
• Tanijiri T, Shimizu T, Uehira K, Yokoi T, Amuro H, Sugimoto H, Torii Y, Tajima K, Ito T, Amakawa R et al. Hodgkin's reed-sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells. J Leukoc Biol 2007; 82:576-84; PMID:17545218; http://dx.doi.org/10.1189/jlb.0906565
   PubMed Web of Science ®Google Scholar
• Cattaruzza L, Gloghini A, Olivo K, Di Francia R, Lorenzon D, De Filippi R, Carbone A, Colombatti A, Pinto A, Aldinucci D. Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma. Int J Cancer 2009; 125:1092-101; PMID:19391137; http://dx.doi.org/10.1002/ijc.24389
   PubMed Web of Science ®Google Scholar
• Yamamoto R, Nishikori M, Kitawaki T, Sakai T, Hishizawa M, Tashima M, Kondo T, Ohmori K, Kurata M, Hayashi T et al. PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma. Blood 2008; 111:3220-4; PMID:18203952; http://dx.doi.org/10.1182/blood-2007-05-085159
   PubMed Web of Science ®Google Scholar
• Kim LH, Eow GI, Peh SC, Poppema S. The role of CD30, CD40 and CD95 in the regulation of proliferation and apoptosis in classical Hodgkin's lymphoma. Pathology 2003; 35:428-35; PMID:14555388; http://dx.doi.org/10.1080/00313020310001602567
   PubMed Web of Science ®Google Scholar
• Huang X, van den Berg A, Gao Z, Visser L, Nolte I, Vos H, Hepkema B, Kooistra W, Poppema S, Diepstra A. Expression of HLA class I and HLA class II by tumor cells in Chinese classical Hodgkin lymphoma patients. PLoS One 2010; 5:e10865; PMID:20526359; http://dx.doi.org/10.1371/journal.pone.0010865
   PubMed Web of Science ®Google Scholar
• Lee SP, Constandinou CM, Thomas WA, Croom-Carter D, Blake NW, Murray PG, Crocker J, Rickinson AB. Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognition. Blood 1998; 92:1020-30; PMID:9680372
   PubMed Web of Science ®Google Scholar
• Steidl C, Shah SP, Woolcock BW, Rui L, Kawahara M, Farinha P, Johnson NA, Zhao Y, Telenius A, Neriah SB et al. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 2011; 471:377-81; PMID:21368758; http://dx.doi.org/10.1038/nature09754
   PubMed Web of Science ®Google Scholar
• Mathas S, Janz M, Hummel F, Hummel M, Wollert-Wulf B, Lusatis S, Anagnostopoulos I, Lietz A, Sigvardsson M, Jundt F et al. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat Immunol 2006; 7:207-15; PMID:16369535; http://dx.doi.org/10.1038/ni1285
   PubMed Web of Science ®Google Scholar
• Tiacci E, Döring C, Brune V, van Noesel CJ, Klapper W, Mechtersheimer G, Falini B, Küppers R, Hansmann ML. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma. Blood 2012; 120:4609-20; PMID:22955914; http://dx.doi.org/10.1182/blood-2012-05-428896
   PubMed Web of Science ®Google Scholar
• Kamesaki H, Fukuhara S, Tatsumi E, Uchino H, Yamabe H, Miwa H, Shirakawa S, Hatanaka M, Honjo T. Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease. Blood 1986; 68:285-92; PMID:3013343
   PubMed Web of Science ®Google Scholar
• Drexler HG. Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines. Leuk Lymphoma 1993; 9:1-25; PMID:7682880; http://dx.doi.org/10.3109/10428199309148499
   PubMed Web of Science ®Google Scholar
• Fisher RI B-BF, Sauder DN, Scala G, Diehl V. Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures. J Immunol 1983; 130:2666-70; PMID:6222113
   PubMed Web of Science ®Google Scholar
• Fisher RI BS, Bostick-Bruton F, Tuteja N, Diehl V. Neoplastic cells obtained from Hodgkin's disease function as accessory cells for mitogen-induced human T cell proliferative responses. J Immunol 1984; 132:2672-7; PMID:6609204
   PubMed Web of Science ®Google Scholar
• Shafer JA, Cruz CR, Leen AM, Ku S, Lu A, Rousseau A, Heslop HE, Rooney CM, Bollard CM, Foster AE. Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma. Leuk Lymphoma 2010; 51:870-80; PMID:20367572; http://dx.doi.org/10.3109/10428191003713968
   PubMed Web of Science ®Google Scholar
• Ho WT, Pang WL, Chong SM, Castella A, Al-Salam S, Tan TE, Moh MC, Koh LK, Gan SU, Cheng CK et al. Expression of CD137 on Hodgkin and Reed-Sternberg cells inhibits T-cell activation by eliminating CD137 ligand expression. Cancer Res 2013; 73:652-61; PMID:23204227; http://dx.doi.org/10.1158/0008-5472.CAN-12-3849
   PubMed Web of Science ®Google Scholar
• Fisher RI, Cossman J, Diehl V, Volkman DJ. Antigen presentation by Hodgkin's disease cells. J Immunol 1985; 135:3568-71; PMID:3876389
   PubMed Web of Science ®Google Scholar
• Di Stasi A, De Angelis B, Rooney CM, Zhang L, Mahendravada A, Foster AE, Heslop HE, Brenner MK, Dotti G, Savoldo B. T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model. Blood 2009; 113:6392-402; PMID:19377047; http://dx.doi.org/10.1182/blood-2009-03-209650
   PubMed Web of Science ®Google Scholar
• Ito A, Ishida T, Yano H, Inagaki A, Suzuki S, Sato F, Takino H, Mori F, Ri M, Kusumoto S et al. Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model. Cancer Immunol Immunother 2009; 58:1195-206; PMID:19048251; http://dx.doi.org/10.1007/s00262-008-0632-0
   PubMed Web of Science ®Google Scholar
• King MA, Covassin L, Brehm MA, Racki W, Pearson T, Leif J, Laning J, Fodor W, Foreman O, Burzenski L et al. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 2009; 157:104-18; PMID:19659776; http://dx.doi.org/10.1111/j.1365-2249.2009.03933.x
   PubMed Web of Science ®Google Scholar
• Fromm JR, Kussick SJ, Wood BL. Identification and purification of classical Hodgkin cells from lymph nodes by flow cytometry and flow cytometric cell sorting. Am J Clin Pathol 2006; 126:764-80; PMID:17050074; http://dx.doi.org/10.1309/7371XK6F6P7474XX
   PubMed Web of Science ®Google Scholar
• Pipitone N, Sinha M, Theodoridis E, Goulding N, Hall M, Lanchbury J, Corrigall V, Panayi G, Pitzalis C. The glucocorticoid inhibition of LFA-1 and CD2 expression by human mononuclear cells is reversed by IL-2, IL-7 and IL-15. Eur J Immunol 2001; 31:2135-42; PMID:11449367; http://dx.doi.org/10.1002/1521-4141(200107)31:7%3c2135::AID-IMMU2135%3e3.0.CO;2-S
   PubMed Web of Science ®Google Scholar
• Engert A, Plutschow A, Eich HT, Lohri A, Dorken B, Borchmann P, Berger B, Greil R, Willborn KC, Wilhelm M et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med 2010; 363:640-52; PMID:20818855; http://dx.doi.org/10.1056/NEJMoa1000067
   PubMed Web of Science ®Google Scholar
• Miyazaki Y, Fujiwara H, Asai H, Ochi F, Ochi T, Azuma T, Ishida T, Okamoto S, Mineno J, Kuzushima K et al. Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia. Blood 2013; 121:4894-901; PMID:23641014; http://dx.doi.org/10.1182/blood-2012-11-465971
   PubMed Web of Science ®Google Scholar
• Landsberg J, Kohlmeyer J, Renn M, Bald T, Rogava M, Cron M, Fatho M, Lennerz V, Wolfel T, Holzel M et al. Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 2012; 490:412-6; PMID:23051752; http://dx.doi.org/10.1038/nature11538
   PubMed Web of Science ®Google Scholar
• Savoldo B, Rooney CM, Di Stasi A, Abken H, Hombach A, Foster AE, Zhang L, Heslop HE, Brenner MK, Dotti G. Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease. Blood 2007; 110:2620-30; PMID:17507664; http://dx.doi.org/10.1182/blood-2006-11-059139
   PubMed Web of Science ®Google Scholar
• Renner C, Bauer S, Sahin U, Jung W, van Lier R, Jacobs G, Held G, Pfreundschuh M. Cure of disseminated xenografted human Hodgkin's tumors by bispecific monoclonal antibodies and human T cells: the role of human T-cell subsets in a preclinical model. Blood 1996; 87:2930-7; PMID:8639913
   PubMed Web of Science ®Google Scholar
• Renner C, Jung W, Sahin U, Denfeld R, Pohl C, Trumper L, Hartmann F, Diehl V, van Lier R, Pfreundschuh M. Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells. Science 1994; 264:833-5; PMID:8171337; http://dx.doi.org/10.1126/science.8171337
   PubMed Web of Science ®Google Scholar
• Hombach A, Kohler H, Rappl G, Abken H. Human CD4+ T cells lyse target cells via granzyme/perforin upon circumvention of MHC class II restriction by an antibody-like immunoreceptor. J Immunol 2006; 177:5668-75; PMID:17015756; http://dx.doi.org/10.4049/jimmunol.177.8.5668
   PubMed Web of Science ®Google Scholar
• Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009; 30:646-55; PMID:19464987; http://dx.doi.org/10.1016/j.immuni.2009.05.001
   PubMed Web of Science ®Google Scholar
• Mucida D, Husain MM, Muroi S, van Wijk F, Shinnakasu R, Naoe Y, Reis BS, Huang Y, Lambolez F, Docherty M et al. Transcriptional reprogramming of mature CD4(+) helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes. Nat Immunol 2013; 14:281-9; PMID:23334788; http://dx.doi.org/10.1038/ni.2523
   PubMed Web of Science ®Google Scholar
• Ma Y, Visser L, Roelofsen H, de Vries M, Diepstra A, van Imhoff G, van der Wal T, Luinge M, Alvarez-Llamas G, Vos H et al. Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes. Blood 2008; 111:2339-46; PMID:18070985; http://dx.doi.org/10.1182/blood-2007-09-112128
   PubMed Web of Science ®Google Scholar
• da Costa L, Renner C, Hartmann F, Pfreundschuh M. Immune recruitment by bispecific antibodies for the treatment of Hodgkin disease. Cancer Chemother Pharmacol 2000; 46 Suppl:S33-6; PMID:10950145; http://dx.doi.org/10.1007/PL00014047
   PubMedGoogle Scholar
• Hombach A, Muche JM, Gerken M, Gellrich S, Heuser C, Pohl C, Sterry W, Abken H. T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells. Gene Ther 2001; 8:891-5; PMID:11423937; http://dx.doi.org/10.1038/sj.gt.3301467
   PubMed Web of Science ®Google Scholar
• Huppa JB, Davis MM. T-cell-antigen recognition and the immunological synapse. Nat Rev Immunol 2003; 3:973-83; PMID:14647479; http://dx.doi.org/10.1038/nri1245
   PubMed Web of Science ®Google Scholar
• Küppers R. The biology of Hodgkin's lymphoma. Nat Rev Cancer 2009; 9:15-27; PMID:19078975; http://dx.doi.org/10.1038/nrc2542
   PubMed Web of Science ®Google Scholar
• McLellan A, Heldmann M, Terbeck G, Weih F, Linden C, Brocker EB, Leverkus M, Kampgen E. MHC class II and CD40 play opposing roles in dendritic cell survival. Eur J Immunol 2000; 30:2612-9; PMID:11009095; http://dx.doi.org/10.1002/1521-4141(200009)30:9%3c2612::AID-IMMU2612%3e3.0.CO;2-G
   PubMed Web of Science ®Google Scholar
• Leverkus M, McLellan AD, Heldmann M, Eggert AO, Brocker EB, Koch N, Kampgen E. MHC class II-mediated apoptosis in dendritic cells: a role for membrane-associated and mitochondrial signaling pathways. Int Immunol 2003; 15:993-1006; PMID:12882837; http://dx.doi.org/10.1093/intimm/dxg099
   PubMed Web of Science ®Google Scholar
• Weber K, Bartsch U, Stocking C, Fehse B. A multicolor panel of novel lentiviral “gene ontology” (LeGO) vectors for functional gene analysis. Mol Ther 2008; 16:698-706; PMID:18362927; http://dx.doi.org/10.1038/mt.2008.6
   PubMed Web of Science ®Google Scholar
• Benz AH, Renne C, Maronde E, Koch M, Grabiec U, Kallendrusch S, Rengstl B, Newrzela S, Hartmann S, Hansmann ML et al. Expression and functional relevance of cannabinoid receptor 1 in Hodgkin lymphoma. PLoS One 2013; 8:e81675; PMID:24349109; http://dx.doi.org/10.1371/journal.pone.0081675
   PubMed Web of Science ®Google Scholar
• Hartmann S, Agostinelli C, Klapper W, Korkolopoulou P, Koch K, Marafioti T, Piccaluga PP, Patsouris E, Pileri S, Hansmann ML. Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel Lymph Node Registry: what is Lennert's lymphoma nowadays? Histopathology 2011; 59:1173-82; PMID:22175897; http://dx.doi.org/10.1111/j.1365-2559.2011.04069.x
   PubMed Web of Science ®Google Scholar